Literature DB >> 17825949

Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.

G Esendagli1, K Bruderek, T Goldmann, A Busche, D Branscheid, E Vollmer, S Brandau.   

Abstract

Even though the lung represents a special immune compartment with the capacity of a high inflammatory response, ineffective anti-tumour immunity is common in lung-associated malignancies. We asked whether a differential composition of the immune cell infiltrate in malignant (MLTAs) and non-malignant lung tissue areas (N-MLTAs) exists and might potentially contribute to this effect. We performed a comparative analysis of immune cells residing in MLTAs and N-MLTAs of non-small cell lung cancer (NSCLC) patients. To this end, we used immunophenotyping and functional analyses on directly isolated immune cells and tissue arrays on archived paraffin-embedded specimens. A strong T cell infiltration was prominent in both tissue compartments whereas CD4(+)CD25(+)CD127(-) T regulatory cells were present in MLTAs only. Nonetheless, concurrent functional ex vivo T cell analyses revealed no significant difference between T cells of MLTA and N-MLTA, suggesting that tumour-infiltrating T cells were not functionally impaired. Interestingly, T cell infiltration was less pronounced in specimens with a high neutrophilic infiltrate. NK cell infiltration was strikingly heterogenous between MLTA and N-MLTA. While NK cells were almost absent in the malignant tissue regions, non-malignant counterparts were selectively populated by NK cells and those NK cells showed strong cytotoxic activity ex vivo. We report that malignant and non-malignant tissue areas in NSCLC are selectively infiltrated by certain immune cell types with NK cells being displaced from the tumour tissue. These phenomena have important implications for tumour immunology of NSCLC and should be considered for the development of future immunologic intervention therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825949     DOI: 10.1016/j.lungcan.2007.07.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  42 in total

1.  Lung Cancer Subtypes Generate Unique Immune Responses.

Authors:  Stephanie E Busch; Mark L Hanke; Julia Kargl; Heather E Metz; David MacPherson; A McGarry Houghton
Journal:  J Immunol       Date:  2016-10-31       Impact factor: 5.422

Review 2.  NK cells: key to success of DC-based cancer vaccines?

Authors:  Eva Lion; Evelien L J M Smits; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-08-20

Review 3.  TGFβ in T cell biology and tumor immunity: Angel or devil?

Authors:  Eric Tu; Pei Zhi Cheryl Chia; Wanjun Chen
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-29       Impact factor: 7.638

4.  Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer.

Authors:  Suliman Y Al Omar; Ernie Marshall; Derek Middleton; Stephen E Christmas
Journal:  Immunology       Date:  2011-02-22       Impact factor: 7.397

Review 5.  Role of natural killer cells in lung cancer.

Authors:  Ozge Nur Aktaş; Ayşe Bilge Öztürk; Baran Erman; Suat Erus; Serhan Tanju; Şükrü Dilege
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-03       Impact factor: 4.553

6.  Adenocarcinoma contains more immune tolerance regulatory t-cell lymphocytes (versus squamous carcinoma) in non-small-cell lung cancer.

Authors:  Candice C Black; Mary Jo Turk; Konstantin Dragnev; James R Rigas
Journal:  Lung       Date:  2013-03-15       Impact factor: 2.584

7.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16

8.  Alteration of the immunological synapse in lung cancer: a microenvironmental approach.

Authors:  S Derniame; J-M Vignaud; G C Faure; M C Béné
Journal:  Clin Exp Immunol       Date:  2008-08-29       Impact factor: 4.330

Review 9.  The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.

Authors:  Robin J Prestwich; Fiona Errington; Rosa M Diaz; Hardev S Pandha; Kevin J Harrington; Alan A Melcher; Richard G Vile
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

10.  An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth.

Authors:  T Liu; A K Chopra
Journal:  Cancer Gene Ther       Date:  2009-08-28       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.